01 5Haruropi
02 5Requip
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 9
2019 Revenue in Millions : 1
Growth (%) : 800
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 26
2020 Revenue in Millions : 9
Growth (%) : 244
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 30
2021 Revenue in Millions : 26
Growth (%) : 16
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 30
2022 Revenue in Millions : 30
Growth (%) : 13
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 155
2014 Revenue in Millions : 132
Growth (%) : -15%
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : -12.80%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 144
2015 Revenue in Millions : 115
Growth (%) : 25
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 155
2016 Revenue in Millions : 164
Growth (%) : -5
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 113
2017 Revenue in Millions : 146
Growth (%) : -23%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 1
2018 Revenue in Millions : 0
Growth (%) : 0
LOOKING FOR A SUPPLIER?
